Diverse cellular TGF-β1 and TGF-β3 gene expression in normal human and murine lung

European Respiratory Journal

Volumn 9, Issue 12, 1996, Pages 2501-2507

  Coker, R K ^a,d   Laurent, G J ^a   Shahzeidi, S ^a   Hernandez Rodriguez N A ^b   Pantelidis, P ^c   Du Bois, R M ^c   Jeffery, P K ^c   McAnulty, R J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^c ROYAL BROMPTON HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

digoxigenin; gene expression; in situ hybridization; lung; transforming growth factor

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LUNG DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 0029905248     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09122501     Document Type: Article

References (35)

1. Robinson DS, Durham SR, Kay AB. Cytokines in asthma. Thorax 1993; 48: 845-853.
2. 22-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol 1594; 98: 319-322.
3. Bergh J. The expression of the platelet-derived and transforming growth factor genes in human non-small lung cancer cell lines is related to tumor stroma formation in nude mice tumors. Am J Pathol 1988; 133: 434-439.
4. 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991; 88: 6642-6646.
5. 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung diseases. Histopathology 1994; 24: 145-150.
6. 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991; 115: 1091-1105.
7. 3 genes during mouse embryogenesis. Development 1991; 111: 117-130.
8. 3 mRNA and protein in the murine lung. Am J Respir Cell Mol Biol 1991; 5: 522-530.
9. Roberts AB, Sporn MB. The transforming growth factor-βs. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors. Handbook of Experimental Pharmacology. Vol. 95/1. Berlin, Springer-Verlag, 1990; pp. 419-472.
10. 3 to cutaneous rat wounds reduces scarring. J Cell Science 1995; 108: 985-1002.
11. Shahzeidi S, Mulier B, de Crombrugghe B, Jeffery PK, McAnulty RJ, Laurent GJ. Enhanced type III collagen gene expression during bleomycin-induced lung fibrosis. Thorax 1993; 48: 622-628.
12. Shahzeidi S, Jeffery PK, Laurent GJ, McAnulty RJ. Increased type I procollagen mRNA transcripts in the lungs of mice during the development of bleomycin-induced fibrosis. Eur Respir J 1994; 7: 1938-1943.
13. Jeffery PK. Microscopic structure of normal lung. In: Brewis RAL, Gibson GJ, Geddes DM, eds. Textbook of Respiratory Medicine, 1st edn. London, Baillière Tindall, 1990; pp. 57-78.
14. Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. 2nd edn. New York, Cold Spring Harbor Laboratory, 1989.
15. Perkett EA, Pelton RW, Meyrick B, Gold LI, Miller DA. Expression of transforming growth factor-β mRNAs and proteins in pulmonary vascular remodeling in the sheep air embolization model of pulmonary hypertension. Am J Respir Cell Mol Biol 1994; 11: 16-24.
16. Cox KH, DeLeon DV, Angerer LM, Angerer RC. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Bid 1984; 101: 485-502.
17. Ponder BA, Wilkinson MM. Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry. J Histochem Cytochem 1981; 29: 981-984.
18. Tautz D, Hülskamp M, Sommer RJ. Whole mount in situ hybridization in Drosophila. In: Wilkinson DG, ed. In Situ Hybridization: A Practical Approach. Oxford, Oxford University Press, 1992; pp. 63.
19. 1 and tumor necrosis factor-α. J Immunol 1992; 149: 103-106.
20. Karr LJ, Panoskaltsis-Mortari A, Li J, Deore-Carter D, Weaver CT, Bucy RP. In situ hybridization for cytokine mRNA with digoxigenin-labeled riboprobes: sensitivity of detection and double label applications. J Immunol Methods 1995; 182: 93-106.
21. Magnan A, Frachon I, Rain B, et al. Transforming growth factor-β in normal human lung: preferential location in bronchial epithelial cells. Thorax 1994; 49: 789-792.
22. 1gene expression in human airways. Thorax 1994; 49: 225-232.
23. Masui T, Wakefield LM, Lechner JF, La Veck MA, Sporn MB, Harris CC. Type-β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sc USA 1986; 83: 2438-2442.
24. Baird A, Durkin T. Inhibition of endothelial cell proliferation by type-β transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochem Biophys Res Commun 1986; 138: 476-482.
25. Müler G, Behrens J, Nussbaumer U, Böhlen P, Birchmeier W. Inhibitory action of transforming growth factor-β on endothelial cells. Proc Natl Acad Sci USA 1987; 84: 5600-5604.
26. Fynan TM, Reiss M. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit Rev Oncogen 1993; 4: 493-540.
27. Evans MJ, Cabral-Anderson LJ, Freeman G. Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest 1978; 38: 648-655.
28. Adamson IYR, Bowden DH. The type 2 cell as progenitor of alveolar epithelial regeneration: a cytodynamic study in mice after exposure to oxygen. Lab Invest 1974; 30: 35-42.
29. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type-β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84: 6020-6024.
30. Shaw RJ, Benedict SH, Clark RAF, King Jr TE. Pathogenesis of pulmonary fibrosis in interstitial lung disease. Am Rev Respir Dis 1991; 143: 167-173.
31. Tsunawaki S, Sporn MB, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-β. Nature 1988; 334: 260-262.
32. 1, gene results in multifocal inflammatory disease. Nature 1992; 359: 693-699.
33. van Vlasselaer P, Punnonen J, de Vries JE. Transforming growth factor-β directs IgA switching in human B-cells. J Immunol 1992; 148: 2062-2067.
34. 2 but not procollagen synthesis via a pertussis toxin-sensitive G-protein. Biochem J 1995; 307: 63-68.
35. Mays PK, McAnulty RJ, Campa JS, Laurent GJ. Age-related changes in collagen synthesis and degradation in rat tissues. Biochem J 1991; 276: 307-313.